Opportunity
Simpler Grants.gov #CDC-RFA-PS-27-0008
CDC Grant for STI Prevention and Control Programs in US Health Departments
Buyer
Centers for Disease Control - NCHHSTP
Posted
May 11, 2026
Respond By
August 29, 2026
Identifier
CDC-RFA-PS-27-0008
NAICS
923120
This funding opportunity from the Centers for Disease Control and Prevention (CDC) supports US health departments in preventing and controlling sexually transmitted infections (STIs): - Government Buyer: - Centers for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) - Program Overview: - Cooperative agreement grant for state, district, territorial, and local health departments - Focus on tracking, preventing, and controlling syphilis, gonorrhea, and chlamydia - Supports the Sexually Transmitted Infections National Strategic Plan 2021-2025 - Eligible Applicants: - All US states, District of Columbia, Puerto Rico, US Virgin Islands, and select cities - Funding determined by population size and STI morbidity - Program Requirements: - Demonstrate capacity for surveillance data reporting - Collaborate with partners to address comorbidities and sexual health - Focus on populations disproportionately impacted by STIs - Implement innovative prevention technologies and coordinated efforts - Products/Services Requested: - No specific OEMs, vendors, or commercial products required - Funding is for public health program implementation, not product procurement
Description
The Centers for Disease Control (CDC) is funding programs aimed at tracking, preventing, and controlling sexually transmitted infections (STIs) in state, district, territorial, and city or county health departments. The focus is on three common STIs: syphilis, gonorrhea, and chlamydia. The program supports the goals of the Sexually Transmitted Infections National Strategic Plan 2021-2025, including preventing new STIs, improving health outcomes, implementing prevention technology, reducing impact in disproportionately affected populations, and achieving coordinated efforts to address the STI epidemic. Local surveillance data will guide priority populations, and collaboration with partners is necessary to address interconnected health issues.